Hi Meirluc:
Thank you for your calm and light-hearted approach.
I agree, it seems likely that if #murcidencel works for GBM, it should work for other types of solid tumors, as well.
The point I was trying to make has to do with the quality of evidence upon which to base an opinion or make a financial investment.
I'm trying to say that evidence that has been vetted by objective third parties and published in peer-reviewed journals deserves more credibility than evidence that is presented by a company employee whose information that hasn't been vetted by anyone else, especially when the employee works for a company that has a huge amount to gain, is heavily invested in the outcome.
But that's just my opinion/perspective.
I'm glad you feel optimistic, and maybe there are many others like you out there. Perhaps that's why the share price has been rising lately. The recent rise has certainly been a welcome development from my perspective.
Best wishes to you,
-- OJ
Market Data 
Markets 
AI
